JY
ENSC icon

Jeff Yass’s Ensysce Biosciences ENSC Stock Holding History

Jeff Yass’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19
Closed -$60K – 13399
2022
Q2 		$60K Sell
19
-6
-24% -$16.8K ﹤0.01% 11868
2022
Q1 		$102K Buy
+25
New +$165K ﹤0.01% 11895

Other funds holding ENSC

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Jeff Yass's ENSC Position: Q2 2026 in Review

Jeff Yass opened a new position in Ensysce Biosciences (ENSC) in Q2 2026: 34,280 shares worth $9.94K. The stake represents ﹤0.01% of the portfolio and ranks #13137 among its holdings. This is a return to the name: Jeff Yass previously reported a position in ENSC as recently as Q4 2022.

Jeff Yass first reported a position in ENSC in Q2 2022 and has held it in 3 quarters since. The position peaked at $13.2K in Q4 2022. 18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

  • Jeff Yass held 34,280 shares of Ensysce Biosciences worth $9.94K as of Q2 2026.
  • Ensysce Biosciences was a new Jeff Yass position in Q2 2026.
  • Ensysce Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13137 holding.
  • Jeff Yass first reported a position in Ensysce Biosciences in Q2 2022 and has held it in 3 quarters since.
  • Jeff Yass's Ensysce Biosciences position peaked at $13.2K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.